Renaissance Technologies’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$382K Buy
522,925
+12,297
+2% +$8.99K ﹤0.01% 2962
2025
Q1
$412K Buy
+510,628
New +$412K ﹤0.01% 2818
2024
Q4
Sell
-432,068
Closed -$449K 3602
2024
Q3
$449K Buy
432,068
+37,240
+9% +$38.7K ﹤0.01% 2836
2024
Q2
$683K Buy
394,828
+242,500
+159% +$420K ﹤0.01% 2535
2024
Q1
$364K Buy
+152,328
New +$364K ﹤0.01% 3002
2022
Q4
Sell
-52,800
Closed -$507K 4138
2022
Q3
$507K Sell
52,800
-152,700
-74% -$1.47M ﹤0.01% 2928
2022
Q2
$1.49M Buy
205,500
+41,400
+25% +$300K ﹤0.01% 2418
2022
Q1
$2.12M Buy
164,100
+108,300
+194% +$1.4M ﹤0.01% 2192
2021
Q4
$891K Buy
+55,800
New +$891K ﹤0.01% 2736
2021
Q2
Sell
-230,700
Closed -$3.37M 3486
2021
Q1
$3.37M Sell
230,700
-30,500
-12% -$446K ﹤0.01% 1897
2020
Q4
$4.54M Buy
261,200
+179,300
+219% +$3.12M ﹤0.01% 1657
2020
Q3
$1.5M Sell
81,900
-324,200
-80% -$5.95M ﹤0.01% 2286
2020
Q2
$7.25M Buy
406,100
+326,200
+408% +$5.83M 0.01% 1408
2020
Q1
$1.3M Sell
79,900
-48,100
-38% -$780K ﹤0.01% 2293
2019
Q4
$2.31M Buy
+128,000
New +$2.31M ﹤0.01% 2254
2018
Q4
Sell
-17,100
Closed -$282K 3396
2018
Q3
$282K Buy
+17,100
New +$282K ﹤0.01% 3039
2017
Q3
Sell
-21,900
Closed -$314K 3211
2017
Q2
$314K Sell
21,900
-91,300
-81% -$1.31M ﹤0.01% 2890
2017
Q1
$2.39M Buy
+113,200
New +$2.39M ﹤0.01% 2141
2016
Q3
Sell
-94,500
Closed -$1.6M 3338
2016
Q2
$1.6M Buy
+94,500
New +$1.6M ﹤0.01% 2325
2015
Q4
Sell
-85,500
Closed -$1.71M 3286
2015
Q3
$1.71M Buy
85,500
+44,593
+109% +$893K ﹤0.01% 2096
2015
Q2
$1.18M Buy
+40,907
New +$1.18M ﹤0.01% 2359